Patent Issues in the Development of Biosimilar Medicines 2011 deals with Opportunities in EU and in developing markets , Development of Moncolonal antibodies regulation, Insulin analogues and pegylation and IP of biosimilars in advanced markets .
The event brings together Executives from R&D, Operations, Market Intelligence, Business Analysis, API Outsourcing, Business Development, Commercial, Product Planning, Project and Portfolio Management, Business Development, Intellectual Property, Regulatory Affairs, Generics, Biopharmaceuticals, Biologics, Product Management and Patents.
Past Events
Patent Issues in the Development of Biosimilar Medicines 2011 - 21 Jul 2011, London, United Kingdom (15094)
Patent Issues in the Development of Biosimilar Medicines 2026
Important
Please, check "Patent Issues in the Development of Biosimilar Medicines" official website for possible changes, before making any traveling arrangements
